Results 221 to 230 of about 2,146,909 (263)

China Stroke Prevention and Control Report 2024: An executive summary. [PDF]

Brain Circ
National Program for Stroke Prevention and Million Disability Reduction Initiative Expert Committee.
europepmc   +1 more source

TAB2 Causes Neuronal Damage by Aggravating Microglia‐Mediated Neuroinflammation in Parkinson's Disease

Advanced Science, EarlyView.
In microglia, STAT3 upregulates TAB2, which promotes NF‐κB activation through its NZF domain‐mediated recognition of K63‐linked ubiquitin chains, leading to inflammatory cytokine release and subsequent neuronal injury. Lumacaftor suppresses TAB2 expression and directly binds the TAB2‐NZF domain to interrupt K63 ubiquitin recognition, thereby blocking ...
Yanhao Zhao, Zimeng Huang, Jianing Gao, Aolan Li, Huizhi Wang, Yingchuan Chen, Guanyu Zhu, Xin Zhang, Yin Jiang, Moxuan Zhang, Fangang Meng, Jianguo Zhang, Tingting Du   +12 more
wiley   +1 more source

Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation: The STABLED Randomized Clinical Trial.

JAMA Neurol
Kimura K, Nishiyama Y, Iwasaki YK, Shimizu W, Toyoda K, Sakamoto Y, Katano T, Yamamoto T, Takeuchi M, Kumagai K, Tsuto K, Sugi K, Kusano K, Koga M, Okubo S, Sato T, Hamaguchi H, Yoshida A, Kuriki A, Tanno K, Kitagawa K, Hagiwara N, Daida H, Iguchi Y, Fujimoto S, Miyamoto S, Fukuzawa M, Sugimoto M, Takita A, Otsuka T, Okumura K.   +30 more
europepmc   +1 more source

GLP-1 Receptor Agonists in Acute Ischemic Stroke and Secondary Stroke Prevention: A Narrative Review of Preclinical and Clinical Evidence. [PDF]

J Cent Nerv Syst Dis
Samanidou V, Tsamis K, Ceasovschih A, Koufakis T, Patoulias D, Rizos EC, Rizzo M, Milionis H, Barkas F.   +8 more
europepmc   +1 more source

Temporal trends in stroke-prevention medication use in patients with atrial fibrillation and chronic obstructive pulmonary disease. [PDF]

Front Pharmacol
Shen CW, Kitikannakorn N, Chen CY, Sirichanchuen B, Jenraumjit R, Liao KM.   +5 more
europepmc   +1 more source

Edoxaban for Stroke Prevention in Atrial Fibrillation in Spain and Portugal: 4-Year Follow-Up of the Observational ETNA-AF-Europe Study. [PDF]

J Clin Med
Barón-Esquivias G, Monteiro P, Santiago-Ruiz JL, Basterra-Trincado L, Vieira Dos Santos L, Ruivo J, Fronk EM, Kirchhof P, De Caterina R.   +8 more
europepmc   +1 more source

Perceptions of Family Support in the Stroke Prevention Program Make My Day. [PDF]

Can J Occup Ther
Norefors K, Asaba E, Åkesson E, Farias L, Patomella AH.   +4 more
europepmc   +1 more source